Rhumbline Advisers Repligen Corp Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Repligen Corp stock. As of the latest transaction made, Rhumbline Advisers holds 143,410 shares of RGEN stock, worth $17.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
143,410
Previous 151,749 5.5%
Holding current value
$17.9 Million
Previous $19.1 Million 11.57%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$119.79 - $167.35 $998,928 - $1.4 Million
-8,339 Reduced 5.5%
143,410 $21.3 Million
Q2 2024

Aug 01, 2024
SELL
$120.0 - $182.95 $741,000 - $1.13 Million
-6,175 Reduced 3.91%
151,749 $19.1 Million
Q1 2024

May 09, 2024
BUY
$170.78 - $208.42 $142,942 - $174,447
837 Added 0.53%
157,924 $29 Million
Q4 2023

Feb 08, 2024
SELL
$114.17 - $185.35 $348,332 - $565,502
-3,051 Reduced 1.91%
157,087 $28.2 Million
Q3 2023

Nov 09, 2023
SELL
$138.78 - $176.51 $282,000 - $358,668
-2,032 Reduced 1.25%
160,138 $25.5 Million
Q2 2023

Aug 08, 2023
BUY
$138.42 - $180.31 $506,617 - $659,934
3,660 Added 2.31%
162,170 $22.9 Million
Q1 2023

May 11, 2023
BUY
$154.26 - $198.1 $554,256 - $711,773
3,593 Added 2.32%
158,510 $26.7 Million
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $548,979 - $745,492
3,380 Added 2.23%
154,917 $26.2 Million
Q3 2022

Nov 10, 2022
BUY
$160.42 - $256.21 $488,478 - $780,159
3,045 Added 2.05%
151,537 $28.4 Million
Q2 2022

Aug 11, 2022
BUY
$140.68 - $188.02 $1.36 Million - $1.82 Million
9,662 Added 6.96%
148,492 $24.1 Million
Q1 2022

May 12, 2022
SELL
$161.19 - $257.96 $53,515 - $85,642
-332 Reduced 0.24%
138,830 $26.1 Million
Q4 2021

Feb 10, 2022
BUY
$247.59 - $304.47 $938,861 - $1.15 Million
3,792 Added 2.8%
139,162 $36.9 Million
Q3 2021

Nov 12, 2021
SELL
$194.77 - $324.21 $152,699 - $254,180
-784 Reduced 0.58%
135,370 $39.1 Million
Q2 2021

Aug 05, 2021
SELL
$165.87 - $220.95 $368,397 - $490,729
-2,221 Reduced 1.61%
136,154 $27.2 Million
Q1 2021

May 06, 2021
SELL
$180.37 - $226.26 $35,172 - $44,120
-195 Reduced 0.14%
138,375 $26.9 Million
Q4 2020

Feb 10, 2021
SELL
$148.08 - $206.57 $128,681 - $179,509
-869 Reduced 0.62%
138,570 $26.6 Million
Q3 2020

Nov 12, 2020
SELL
$122.51 - $158.27 $175,434 - $226,642
-1,432 Reduced 1.02%
139,439 $20.6 Million
Q2 2020

Aug 13, 2020
SELL
$94.33 - $140.48 $1.34 Million - $1.99 Million
-14,164 Reduced 9.14%
140,871 $17.4 Million
Q1 2020

May 06, 2020
SELL
$84.96 - $109.14 $222,000 - $285,182
-2,613 Reduced 1.66%
155,035 $15 Million
Q4 2019

Feb 05, 2020
BUY
$73.84 - $93.08 $328,292 - $413,833
4,446 Added 2.9%
157,648 $14.6 Million
Q3 2019

Oct 23, 2019
BUY
$76.65 - $95.51 $1.27 Million - $1.58 Million
16,531 Added 12.1%
153,202 $11.7 Million
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $389,914 - $618,324
7,194 Added 5.56%
136,671 $11.7 Million
Q1 2019

May 01, 2019
BUY
$49.45 - $62.8 $57,807 - $73,413
1,169 Added 0.91%
129,477 $7.65 Million
Q4 2018

Jan 31, 2019
BUY
$48.26 - $68.88 $875,050 - $1.25 Million
18,132 Added 16.46%
128,308 $6.77 Million
Q3 2018

Nov 07, 2018
SELL
$46.8 - $58.97 $3,463 - $4,363
-74 Reduced 0.07%
110,176 $6.11 Million
Q2 2018

Aug 06, 2018
BUY
$35.26 - $47.04 $164,170 - $219,018
4,656 Added 4.41%
110,250 $5.19 Million
Q1 2018

May 02, 2018
BUY
$30.92 - $37.27 $88,431 - $106,592
2,860 Added 2.78%
105,594 $3.82 Million
Q4 2017

Feb 09, 2018
BUY
$32.53 - $38.92 $442,863 - $529,856
13,614 Added 15.28%
102,734 $3.73 Million
Q3 2017

Nov 06, 2017
BUY
$36.98 - $46.06 $3.3 Million - $4.1 Million
89,120
89,120 $3.42 Million

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email